Indian pharma exports stands at $17 billion at present and grew 9.4 per cent in 2015-16, said a report. The domestic pharma industry exports $12.7 billion worth of pharma goods in the generic category, which is 5.8 per cent of the overall global generic market.

Regulatory headwinds that have emerged in 2016 are likely to impact earnings of some of the top pharma companies, say experts. But those looking to invest in the sector should have a long-term horizon, they said.